FOLH1 and neoplasm: In the case of Dual-RevCAR T cells, potent tumor cell killing only occurred in the simultaneous presence of the RevTM PSMA-7B6 and the RevTM PSCA-5B9 stimulating SIG RevCAR-E7B6-3z and COS RevCAR-E5B9-28, respectively (Figure 7A).